Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1050 posts found.

BMS breast cancer drug rejected

November 27, 2008
Sales and Marketing BMS, Cancer, breast cancer

Bristol-Myers Squibb's breast cancer drug Ixempra has suffered a setback in the EU over safety concerns.The Committee for Medicinal Products …

News

Boehringer’s cancer drug enters phase III

November 21, 2008
Sales and Marketing Boehringer, Cancer

Boehringer Ingelheim's new lung cancer drug Vargatef has entered phase III trials.The drug is part of the manufacturer's burgeoning oncology …

News

Lilly eyes oncology focus with ImClone acquisition

October 9, 2008
Sales and Marketing Cancer, MA, lilly

Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …

News

Gardasil and Cervarix share innovation prize

September 25, 2008
Sales and Marketing Cancer, Gardasil, prix galien, vaccines

Rival vaccine products that will prevent thousands of women developing cervical cancer have been declared joint winners of the prestigious …

News

Brown to scrap prescription costs for cancer patients

September 24, 2008
Cancer, NHS

Patients suffering from cancer won't have to pay for prescriptions after April next year under new government plans. Prime minister …

News

GSK seeks risk-sharing deal for Tyverb

September 17, 2008
Sales and Marketing Cancer, GSK, NICE, par

GlaxoSmithKline has approached the government for a new pricing deal on its breast cancer drug Tyverb, which could make it …

News
Paolo

GSK unveils new cancer unit

September 17, 2008
Research and Development Cancer, GSK

 GSK has unveiled a new integrated oncology R&D unit aimed at enhancing its presence in cancer care.The unit will be …

News

Patient wins legal battle for Revlimid

September 12, 2008
Sales and Marketing Cancer, Revlimid

A cancer patient has won access to cancer drug Revlimid in a court battle with his local PCT. West Sussex …

News

Government looks set to allow top-up fees

September 10, 2008
Sales and Marketing Cancer, Karol Sikora, NICE

 Patients in the UK could soon gain official clearance to pay ‘top up’ fees in order to receive the cancer …

News

European research centres unite to battle cancer

September 9, 2008
Research and Development Cancer, EU, France, Netherlands, Sweden

Top oncology specialists across Holland, France and Sweden have formed a new alliance to improve cancer research and reduce treatment …

News

The Pharmafocus Interview: Martin Dawkins

September 4, 2008
Research and Development, Sales and Marketing Bayer, Cancer, NICE, Xarelto, healthcare

 Martin Dawkins is an Englishman born and bred, but has spent most of his career working abroad, including the US, …

Feature

A new kind of patient advocate

July 30, 2008
Sales and Marketing Cancer, campaigner, market access, patient

When I came to interview Kate Spall, it was she, not I, who fired the first few questions. Her approach …

Feature

Erbitux set for first line treatment of colorectal cancer

June 5, 2008
Sales and Marketing Cancer, Merck Serono

Merck Serono's Erbitux looks set for approval in Europe as a first-line colon cancer treatment. Approved four years ago as …

News

Pfizer invests in oncology for future gains

May 16, 2008
Research and Development, Sales and Marketing Cancer, Pfizer

Pfizer has named Garry Nicholson as head of its new global oncology unit, a venture the company believes will bring …

News

Cancer generics – a booming market

October 9, 2003
Sales and Marketing Cancer, blockbuster, generics

Feature

Latest content

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023

Acesion Pharma raises €45m series B funding

September 26, 2023

CDC Advisory Committee recommends Pfizer’s RSV vaccine

September 25, 2023

FDA approves Eli Lilly and Boehringer Ingelheim’s Jardiance for chronic kidney disease treatment

September 25, 2023

FDA grants ODD to Nexcella’s NXC-201 as treatment for amyloid light chain amyloidosis

September 22, 2023